InvestorsHub Logo
icon url

bigjake

01/12/18 1:34 AM

#1195 RE: Lynx7 #1194

Respecting 5211, at the Biotech Showcase the other day, I believe the CEO indicated they were observing the results over a 24 week period..... the original trial was 12 weeks..... & once compiled, they would release the top line data which he anticipated would be in 1Q18. They would then seek to go to the FDA & review the data with the FDA & discuss the structure of a registration trial. They indicated a hope to have a partner before commencing the registration trial.